Agmatine requires GluN2B-containing NMDA receptors to inhibit the development of neuropathic pain

A decarboxylated form of L-arginine, agmatine, preferentially antagonizes NMDArs containing Glun2B subunits within the spinal cord and lacks motor side effects commonly associated with non-subunit-selective NMDAr antagonism, namely sedation and motor impairment. Spinally delivered agmatine has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Cristina D, Kitto, Kelley F, Verma, Harsha, Pflepsen, Kelsey, Delpire, Eric, Wilcox, George L, Fairbanks, Carolyn A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255568/
https://www.ncbi.nlm.nih.gov/pubmed/34210178
http://dx.doi.org/10.1177/17448069211029171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255568/
https://www.ncbi.nlm.nih.gov/pubmed/34210178
http://dx.doi.org/10.1177/17448069211029171

Ejemplares similares